Drugdocs | Kybella

An independent source of information on U.S. brand name drugs for health professionals

An independent source of information on U.S. brand name drugs for health professionals

Kybella

Chemical Name	deoxycholic acid
Dosage Form	Injection (subcutaneous; 10 mg/mL)
Drug Class	Enzymes
System	Skin
Company	Kythera Biopharms
Approval Year	2015

Indication

To treat adults with moderate-to-severe fat below the chin, known as submental fat.

Last updated on 10/27/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document Title	Year	Source
Kybella (deoxycholic acid) Prescribing Information	2018	Allergan USA, Inc., Irvine, CA

Document Title	Year	Source
ATX-101 (deoxycholic acid injection) for reduction of submental fat: Results from a 12-month open-label study.	2019	Journal of Drugs in Dermatology
A double-blind, placebo-controlled, phase 3b study of ATX-101 for reduction of mild or extreme submental fat.	2019	Dermatologic Surgery